Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

This study has been completed.
Information provided by:
Ranbaxy Inc. Identifier:
First received: February 18, 2010
Last updated: March 1, 2010
Last verified: March 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)